Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas

Radiotherapy and Oncology

Volumn 67, Issue 1, 2003, Pages 35-44

  Nordsmark, Marianne ^a   Loncaster, Juliette ^b   Aquino Parsons, Christina ^c   Chou, Shu Chuan ^d   Ladekarl, Morten ^a   Havsteen, Hanne ^a   Lindegaard, Jacob C ^a   Davidson, Susan E ^b   Varia, Mahesh ^d   West, Catharine ^b   Hunter, Robin ^b   Overgaard, Jens ^a   Raleigh, James A ^d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Hypoxia marker; Pimonidazole; Tumour oxygenation; Uterine cervix carcinoma

Indexed keywords

PIMONIDAZOLE;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROELECTRODE; OXYGEN ELECTRODE; OXYGEN TISSUE LEVEL; POLAROGRAPHY; PRIORITY JOURNAL; TUMOR NECROSIS; UTERINE CERVIX CARCINOMA; UTERUS BIOPSY;

EID: 0037847453     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00010-0     Document Type: Article

References (33)

1. Azuma C., Raleigh J.A., Thrall D. Longevity of pimonidazole adducts in spontaneous canine tumours as an estimate of hypoxic cell lifetime. Radiat Res. 148:1997;35-42.
2. Arteel G.E., Thurman R.G., Yates M., Raleigh J.A. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer. 72:1995;889-895.
3. Arteel G.E., Thurman R.G., Raleigh J.A. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur J Biochem. 253:1998;743-750.
4. Begg A.C., Janssen H., Sprong D., et al. Hypoxia and perfusion measurements in human tumors -initial experience with pimonidazole and IUdR. Acta Oncol. 40:(8):2001;924-928.
5. Bentzen L, Keiding S, Nordsmark M et al. Tumour oxygenation assessed by 18F-Fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours. Radiother Oncol (submitted).
6. Brizel D.M., Scully S.P., Harrelson J.M., et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:1996;941-943.
7. Bussink J., Kaanders J.H., et al. Rijken.Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide. Radiother Oncol. 50:(2):1999;173-184.
8. Denekamp J., Dasu A. Inducible repair and the two forms of tumour hypoxia. Time for a paradigm shift. Acta Oncol. 38:1999;903-918.
9. Evans S., Hahn S., Pook D., et al. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res. (60):2000;2018-2024.
10. Fyles A., Milosevic M., Hedley D., et al. Tumour hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol. 20:2002;680-687.
11. Gross M.W., Karbach U., Groebe K., et al. Calibration of misonidazole labelling by simultaneous measurement of oxygen tension and labelling density in multicellular Spheroids. Int J Cancer. 61:1995;567-573.
12. Höckel M., Vaupel P. Prognostic significance of tissue hypoxia in cervical cancer. J Gynecol Oncol. 6:2001;216-225.
13. Jenkins T.W., Evans S.M., Koch C.J. Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: Comparative measurements using EF5 binding and the Eppendorf needle electrode. Int J Radiat Oncol Biol Phys. 46:2000;1005-1017.
14. Kavanagh M.C., Tsang V., Chow S., et al. A comparison in individual murine tumours of techniques for measuring oxygen levels. Int J Radiat Oncol Biol Phys. 44:1999;1137-1146.
15. Kennedy A.S., Raleigh J.A., Perez G.M., et al. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int J Radiat Oncol Biol Phys. 37:1997;897-905.
16. Loncaster J.A., Harris A.L., Davidson S.E., et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 61:2001;6394-6399.
17. Nordsmark M., Bentzen S.M., Overgaard J. Measurement of human tumor oxygenation status by a polarographic needle. An analysis of inter- and intra-tumor heterogeneity. electrode. Acta Oncol. 33:1994;383-389.
18. Nordsmark M., Overgaard M., Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 41:1996;31-39.
19. Nordsmark M., Alsner J., Keller J., et al. Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations. Br J Cancer. 84:2001;1070-1075.
20. Nordsmark M., Loncaster J., Chou S.C., et al. Invasive oxygen measurements and pimonidazole labelling in human cervix carcinoma. Int J Radiat Oncol Biol Phys. 49:2001;581-586.
21. Olive P.L., Banath J.P., Aquino-Parsons C. Measuring hypoxia in human tumours. Is there a gold standard? Acta Oncol. 40:2001;917-923.
22. Olive P.L., Aquino-Parsons C., MacPhail S.H., et al. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res. 61:(24):2001;8924-8929.
23. Parliament M.B., Franko A.J., Allalunis-Turner M.J., et al. Anomalous patterns of nitroimidazole binding adjacent to necrosis in human glioma xenografts: possible role of decreased oxygen consumption. Br J Cancer. 75:1997;311-318.
24. Raleigh J.A., Miller G.G., Franko A.J., Koch C.J., Fuciarelli A.F., Kelly D.A. Flourescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br J Cancer. 56:1987;395-400.
25. Raleigh J.A., Chou S.C., Arteel G.E., Horsman M.R. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res. 151:1999;580-589.
26. Raleigh J.A., Chou S.C., Bono E.L., et al. Semi-quantitative immunohistochemical analysis for hypoxia in human tumors. Int J Radiat Oncol Biol Phys. 49:2001;569-574.
27. Rampling R., Cruickshank G., Lewis A.D., Fizsimmons S.A., Workman P. Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys. 29:1994;427-431.
28. Saunders M.I., Anderson P.J., Bennett M.H., et al. The clinical testing of Ro 03-8799 - pharmacokinetics, toxicology, tissue and tumor concentrations. Int J Radiat Oncol Biol Phys. 10:1984;1759-1763.
29. Thews O., Vaupel P. Relevant parameters for describing the oxygenation status of solid tumors. Strahlenther. 172:1996;239-243.
30. Thrall D.E., Rosner G.L., Azuma C., McEntee M.C., Raleigh J.A. Hypoxia marker labeling in tumor biopsies: quantification of labelling variation and criteria for biopsy sectioning. Radiother Oncol. 44:1997;171-176.
31. 2 at the cellular level. Br J Cancer. 54:1986;453-457.
32. Vaupel P., Schlenger K., Knoop C., et al. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res. 51:1991;3316-3322.
33. Wong R.K., Fyles A., Milosevic M., et al. Heterogeneity of polarographic oxygen tension measurements in cervix cancer: an evaluation of within and between tumor variability, probe position, and track depth. Int J Radiat Oncol Biol Phys. 39:1997;405-412.